Anti-C. difficile Toxin A Recombinant Antibody (Actoxumab) (CAT#: TAB-716)

Recombinant human monoclonal antibody expressed in CHO binding to toxin A [C. difficile]. Actoxumab is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficileinfection.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Tested Data
  • Datasheet
  • MSDS
  • COA
SDS-PAGE

Figure 1 Anti-C. difficile Toxin A Recombinant Antibody (TAB-716) in SDS-PAGE

Figure 1 Anti-C. difficile Toxin A Recombinant Antibody (TAB-716) in SDS-PAGE

Lane M: Protein Marker Lane 1: 2μg, Non-Reducing Lane 2: 2μg, Reducing


Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG1 - kappa
  • Species Reactivity
  • C. difficile
  • Applications
  • Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, WB and most other immunological methods.
  • CAS
  • 1245634-25-6
  • Generic Name
  • actoxumab
  • MW
  • 145.9 kDa
  • Related Disease
  • Clostridium difficileinfectious diarrhea

Product Property

  • Purity
  • >95.0% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE.
  • Storage
  • Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.

Target

  • Alternative Names
  • actoxumab;1245634-25-6;MDX-066;CDA-1;MBL-CDA1;tcdA;toxA

Related Resources

  • Biosimilar Overview
Please refer to Actoxumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Actoxumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Actoxumab"

Afuco™ Anti-C. diff Toxin A ADCC Recombinant Antibody (Actoxumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to toxin A [C. difficile]. Actoxumab is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficileinfection.

See other products for "C. diff Toxin A"

Single-domain Antibody

CAT Product Name Application Type
NAB-2386-VHH Recombinant Anti-C. diff Toxin A VHH Single Domain Antibody IHC, ICC, IP, ChiP, Neut Llama VHH

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-716. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare